Search

Your search keyword '"M. Doubek"' showing total 330 results

Search Constraints

Start Over You searched for: Author "M. Doubek" Remove constraint Author: "M. Doubek"
330 results on '"M. Doubek"'

Search Results

1. Search for central exclusive production of top quark pairs in proton-proton collisions at s $$ \sqrt{s} $$ = 13 TeV with tagged protons

2. A search for new physics in central exclusive production using the missing mass technique with the CMS detector and the CMS-TOTEM precision proton spectrometer

3. Search for high-mass exclusive γγ → WW and γγ → ZZ production in proton-proton collisions at s $$ \sqrt{s} $$ = 13 TeV

4. Characterisation of the dip-bump structure observed in proton–proton elastic scattering at $$\sqrt{s}$$ s = 8 TeV

5. Erratum to: Measurement of single-diffractive dijet production in proton–proton collisions at $$\sqrt{s} = 8\,\text {Te}\text {V} $$ s = 8 Te with the CMS and TOTEM experiments

6. Measurement of single-diffractive dijet production in proton–proton collisions at $$\sqrt{s} = 8\,\text {Te}\text {V} $$ s = 8 Te with the CMS and TOTEM experiments

7. Elastic differential cross-section $${\mathrm{d}}\sigma /{\mathrm{d}}t$$ dσ/dt at $$\sqrt{s}=2.76\hbox { TeV}$$ s=2.76TeV and implications on the existence of a colourless C-odd three-gluon compound state

9. P676: LOW-DOSE FCR COMPARED TO BR IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITHOUT TP53 ABERRATIONS: A REAL – WORLD RETROSPECTIVE ANALYSIS BY THE CZECH CLL STUDY GROUP.

10. P1282: DISEASE-SPECIFIC U1 SPLICEOSOMAL RNA MUTATIONS IN MATURE B-CELL NEOPLASMS

12. PB2349: LESSONS LEARNED FROM THE MYPAL DIGITAL HEALTH INTERVENTION: CAPITALIZING ON THE PATIENT REPORTED OUTCOMES (PRO) PARADIGM TOWARDS A PARTICIPATORY HEALTHCARE FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

13. Elastic differential cross-section measurement at $$\sqrt{s}=13$$ s=13 TeV by TOTEM

14. First determination of the $${\rho }$$ ρ parameter at $${\sqrt{s} = 13}$$ s=13 TeV: probing the existence of a colourless C-odd three-gluon compound state

15. First measurement of elastic, inelastic and total cross-section at $$\sqrt{s}=13$$ s=13 TeV by TOTEM and overview of cross-section data at LHC energies

16. Observation of proton-tagged, central (semi)exclusive production of high-mass lepton pairs in pp collisions at 13 TeV with the CMS-TOTEM precision proton spectrometer

17. Evidence for non-exponential elastic proton–proton differential cross-section at low |t| and s=8TeV by TOTEM

18. Exogenous lipoid pneumonia caused by chronic improper use of baby body oil in adult patient

19. Chlorambucil and fludarabine as a new pre-transplant conditioning for patients with chronic lymphocytic leukemia: results of in vivo experiments

20. Appearance of iron-labeled blood mononuclear cells in electron microscopy

22. Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL

23. Odderon Exchange from Elastic Scattering Differences between pp and pp[over ¯] Data at 1.96 TeV and from pp Forward Scattering Measurements

24. Elastic differential cross-section measurement at $$\sqrt{s}=13$$ <math><mrow><msqrt><mi>s</mi></msqrt><mo>=</mo><mn>13</mn></mrow></math> TeV by TOTEM

25. First determination of the $${\rho }$$ <math><mi>ρ</mi></math> parameter at $${\sqrt{s} = 13}$$ <math><mrow><msqrt><mi>s</mi></msqrt><mo>=</mo><mn>13</mn></mrow></math> TeV: probing the existence of a colourless C-odd three-gluon compound state

26. First measurement of elastic, inelastic and total cross-section at $$\sqrt{s}=13$$ <math><mrow><msqrt><mi>s</mi></msqrt><mo>=</mo><mn>13</mn></mrow></math> TeV by TOTEM and overview of cross-section data at LHC energies

27. Kongenitální neutropenie u dětí a dospělých.

28. Evidence for non-exponential elastic proton–proton differential cross-section at low |t| and s=8TeV by TOTEM

29. Novel Ultrasonic Instrumentation Developments for Real-time Monitoring of Binary Gas Mixturesand Flow: Description and Applications

30. Dědičná trombocytopenie na podkladě patogenní varianty genu MYH9 diagnostikovaná u dospělé ženy.

31. Measurement of pseudorapidity distributions of charged particles in proton-proton collisions at √s = 8 TeV by the CMS and TOTEM experiments

32. The effects of hypolimnetic anoxia on the diel vertical migration of freshwater crustacean zooplankton

33. The TOTEM detector at LHC

35. Evidence for non-exponential elastic proton–proton differential cross-section at low | t | and s=8TeV by TOTEM

36. Measurement of pseudorapidity distributions of charged particles in proton–proton collisions at (Equation Present) TeV by the CMS and TOTEM experiments

37. Measurement of proton-proton inelastic scattering cross-section at chem{sqrt {s} = 7,{mathrm {TeV}}}

38. Luminosity-Independent Measurement of the Proton-Proton Total Cross Section at $\sqrt{s}$ = 8 TeV

39. A combined ultrasonic flow meter and binary vapour mixture analyzer for the ATLAS silicon tracker

40. [Essential thrombocythaemia and other myeloproliferative disorders with thrombocythaemia treated with Thromboreductin. A report from the database of register for the 1st quarter of 2010]

41. [Treatment of adult acute lymphoblastic leukemia according to GMALL 07/2003 study protocol in the Czech Republic - the first experience]

42. [The results of patients with essentials thrombocythemia and other myeloproliferation-related thrombocythemia--a report of patients treated with Thromboreductin]

43. [Hematologic malignancies in pregnancy]

44. Microarray analysis using a limited amount of cells

45. [Rare diagnosis of CD4+56+ leukemia from dendritic cells type DC2]

46. [What is the current treatment of patients with essential thrombocytopenia and other myeloproliferations accompanied with thrombocythemia [corrected] and what can be the predictive sign of the risk of thrombosis in such patients--a report from the registry of patients treated by Thromboreductine]

47. [Therapy of chronic myeloid leukemia. Uncommon view of the modern approaches]

48. [Essential thrombocytemia and other myeloproliferations with thrombocytemia in the data of the register of patients treated with Thromboreductin till the end of 2006]

49. Is FLT3 internal tandem duplication significant indicator for allogeneic transplantation in acute myeloid leukemia? An analysis of patients from the Czech Acute Leukemia Clinical Register (ALERT)

50. [Molecular genetic characterization of chronic lymphocytic leukemia aggressivity in Czech patients: a nucleotide variability of genes coding for heavy chain of immunoglobulin]

Catalog

Books, media, physical & digital resources